Construction of a Cohort for Pan-Vascular Disease Among Employees of Taizhou People's Hospital

Sponsor
Jiangsu Taizhou People's Hospital
Study ID
NCT06545799
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Cardiovascular Death
  • Myocardial Infarction
  • Stroke

Eligibility Criteria

Sex
ALL
Age
45 Years - N/A
Healthy Volunteers
Accepted

Study Details

1. Participant Recruitment During the annual health check-ups for hospital staff, potential participants are recruited. Those who express interest are provided with a detailed explanation of the study's objectives, content, and procedures, and are required to sign an informed consent form. 2. Screening Phase Medical history is collected, including any previous occurrences of myocardial infarction, ischemic or hemorrhagic stroke, or history of coronary, carotid, or peripheral arterial revascularization. 3. Baseline Data Collection 1\. Health Questionnaire Survey: Collect demographic information, medical history, and data on nutrition, physical activity, and smoking habits through a questionnaire. 2\. Clinical Assessments: Conduct the following assessments for all enrolled participants: * High-sensitivity cardiac troponin I and NT-proBNP testing * Non-invasive arterial stiffness testing * Measurement of visceral and subcutaneous fat content * Fundus photography * Body composition analysis 4 Regular Follow-Up Annual follow-up for a total of 10 years. The follow-up includes: 1. . Collection of updated demographic information and medical history, as well as repeated questionnaires on nutrition, physical activity, and smoking habits. 2. . Reassessment of the following items: * High-sensitivity cardiac troponin I and NT-proBNP testing * Non-invasive arterial stiffness testing * Measurement of visceral and subcutaneous fat content * Fundus photography * Body composition analysis 5 Outcome Evaluation 1）. Primary Outcomes: Cardiovascular mortality, non-fatal myocardial infarction, or non-fatal stroke events. 2）. Secondary Outcomes: All vascular events, changes in cardiovascular biomarkers, and degree of arterial stiffness.

Key Dates

First listed
Aug 9, 2024
Start date
Sep 1, 2024
Status verified
Aug 2024
Primary completion
Sep 1, 2034
Completion
Sep 1, 2034

Study Design

Enrollment
1,000 participants (estimated)

Primary Outcome Measure

Cardiovascular death, non-fatal myocardial infarction, or non-fatal stroke events [ Time Frame: September 2024 to August 2034 ]

Central Contacts

Find similar trials

Nationwide
Stroke trialsNeurology trialsBrain disorders trials

Related Studies